Silver Creek Pharmaceuticals
Walter Anthony Olsen is currently the Director of Downstream Process Development/CMC at Silver Creek Pharmaceuticals, Inc. Walter Anthony has a strong background in process development and project management within the pharmaceutical industry, working with challenging biomolecules and diverse oncology pipelines. Walter's experience includes roles as a CMC Consultant, Associate Director at Silvercreek Pharmaceuticals, and Senior Bioprocess Scientist at Merrimack. Walter Anthony holds a degree in biotechnology, biomedical, and laboratory sciences from Boston University.
This person is not in any teams
This person is not in any offices
Silver Creek Pharmaceuticals
Silver Creek Pharmaceuticals, a biotechnology company, develops protein therapeutics to treat cardiovascular diseases. The company's mission is to provide smart growth factors to those suffering from organ damage as a result of an acute injury. Scp776 is currently being tested in clinical trials for the treatment of stroke.